Comparison of eGFR change rates before and after renal internal medical referral. Before the referral (left orange), the ...

A Diabetes, Heart Failure, and Kidney Disease Medication Is the First of Its Kind to Significantly Reduce Both Heart Attacks and Strokes Feb. 11, 2025 — Over 1,000 genes may serve as possible ...

Employment among patients with kidney disease remains low even after dialysis or a transplant, with physical and social ...

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on ...

In patients with type 2 diabetes, the risk for chronic kidney disease differed among users of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylurea.

Richard Lafayette, MD, FACP, Stanford University Medical Center, explains the significance of this second approval in a month ...

Two significant programs that invested in research on diabetes, dementia, obesity and kidney disease have ended since the ...

Novo Nordisk’s SOUL trial confirms that oral semaglutide significantly reduces the risk of heart attack, stroke, and ...

(Courtesy/GettyImages) Millions of people around the world unknowingly live with a deadly trio: diabetes, high blood pressure and kidney disease. Often, they only realise the connection when it is ...

Medscape News UK, February 27, 2025 Bone-Derived Hormone Predicts Diabetic Kidney Disease Risk Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for ...